We are live on ! Find out more
11A

10-15 Associates Portfolio holdings

AUM $516M
1-Year Est. Return 7.62%
This Fund
S&P 500
This Quarter Est. Return
+5.23%
1 Year Est. Return
+7.62%
3 Year Est. Return
+32.98%
5 Year Est. Return
+79.47%
10 Year Est. Return
AUM
$446M
AUM Growth
+$1.2M
Cap. Flow
-$15.5M
Cap. Flow %
-3.47%
Top 10 Hldgs %
36.26%
Holding
113
New
4
Increased
21
Reduced
72
Closed
12

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$12.4M
2
XLNX
Xilinx Inc
XLNX
+$12.2M
3
ELV icon
Elevance Health
ELV
+$10.8M
4
CB icon
Chubb
CB
+$9.63M
5
GIS icon
General Mills
GIS
+$5.01M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$13.8M
2
AXP icon
American Express
AXP
+$12.8M
3
MET icon
MetLife
MET
+$10.9M
4
WPM icon
Wheaton Precious Metals
WPM
+$4.03M
5
SCHP icon
Schwab US TIPS ETF
SCHP
+$2.77M

Sector Composition

Rank Sector Weight
1 Healthcare 19.68%
2 Financials 13.19%
3 Technology 11.52%
4 Energy 9.59%
5 Communication Services 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VZ icon
1
Verizon
VZ
$208B
$32.7M 7.32%
611,712
-48,444
-7% -$2.56M
PFE icon
2
Pfizer
PFE
$159B
$15.9M 3.57%
380,993
+4,340
+1% +$167K
JPM icon
3
JPMorgan Chase
JPM
$951B
$15.5M 3.47%
137,148
-13,979
-9% -$1.59M
JNJ icon
4
Johnson & Johnson
JNJ
$646B
$15.3M 3.42%
110,639
-2,773
-2% -$368K
CSCO icon
5
Cisco
CSCO
$433B
$15.2M 3.41%
313,246
+5,591
+2% +$251K
PG icon
6
Procter & Gamble
PG
$334B
$13.9M 3.12%
167,503
+6,749
+4% +$552K
RDS.B
7
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$13.7M 3.07%
192,922
+3,391
+2% +$235K
XLNX
8
DELISTED
Xilinx Inc
XLNX
$13.4M 2.99%
+166,696
New +$12.2M
SBUX icon
9
Starbucks
SBUX
$123B
$13.4M 2.99%
+234,960
New +$12.4M
INTC icon
10
Intel
INTC
$473B
$12.9M 2.9%
273,364
+3,310
+1% +$161K
GSK icon
11
GSK
GSK
$102B
$12M 2.69%
238,897
+5,366
+2% +$273K
ABBV icon
12
AbbVie
ABBV
$451B
$11.9M 2.66%
125,562
+6,593
+6% +$625K
SLB icon
13
SLB Ltd
SLB
$85.1B
$11.9M 2.66%
194,811
+3,392
+2% +$218K
PNC icon
14
PNC Financial Services
PNC
$96.6B
$11.5M 2.57%
84,293
-1,206
-1% -$171K
ELV icon
15
Elevance Health
ELV
$85.5B
$11.4M 2.55%
+41,471
New +$10.8M
BA icon
16
Boeing
BA
$166B
$11.2M 2.51%
30,151
-488
-2% -$171K
KKR icon
17
KKR & Co
KKR
$97.6B
$11M 2.46%
403,204
-76,067
-16% -$2.03M
RIO icon
18
Rio Tinto
RIO
$168B
$10.8M 2.42%
211,682
-7,880
-4% -$402K
UPS icon
19
United Parcel Service
UPS
$89.6B
$10.5M 2.36%
90,278
-139
-0.2% -$16.4K
MRK icon
20
Merck
MRK
$366B
$10.5M 2.35%
154,958
+2,782
+2% +$177K
LYB icon
21
LyondellBasell Industries
LYB
$20.6B
$10.1M 2.26%
98,605
+1,960
+2% +$214K
M icon
22
Macy's
M
$5.79B
$10.1M 2.25%
289,641
-68,239
-19% -$2.54M
GIS icon
23
General Mills
GIS
$22.2B
$9.71M 2.18%
226,291
+110,646
+96% +$5.01M
EPD icon
24
Enterprise Products Partners
EPD
$84.3B
$9.54M 2.14%
331,950
-3,613
-1% -$104K
CB icon
25
Chubb
CB
$131B
$9.52M 2.13%
+71,210
New +$9.63M

Similar funds

10-15 Associates's Q3 2018 Portfolio in Review

As of Q3 2018, 10-15 Associates held 113 positions worth $446M, up 0.27% from $445M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

10-15 Associates withdrew a net $15.5M in Q3 2018, closing 12 positions and reducing 72 holdings. Its most notable exit was American Express, an estimated $12.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

Against the trend, 10-15 Associates opened a new position in Starbucks worth $13.4M.

  • 10-15 Associates's largest Q3 2018 buy was Starbucks: 234,960 shares worth $13.4M.
  • 10-15 Associates added most to General Mills in Q3 2018, an estimated $5.01M increase.
  • 10-15 Associates's biggest Q3 2018 reduction was Qualcomm, cutting an estimated $13.8M.
  • 10-15 Associates fully exited American Express in Q3 2018, selling an estimated $12.8M.
  • 10-15 Associates's ten largest holdings make up 36% of its $446M portfolio in Q3 2018.
  • 10-15 Associates opened 4 new positions and closed 12 in Q3 2018.
  • 10-15 Associates's portfolio value rose 0.27% quarter-over-quarter to $446M.

Based on 10-15 Associates's 13F filing for Q3 2018, filed 13 Nov 2018.